152 related articles for article (PubMed ID: 23574716)
1. The significance of a Cripto-1 positive subpopulation of human melanoma cells exhibiting stem cell-like characteristics.
Strizzi L; Margaryan NV; Gilgur A; Hardy KM; Normanno N; Salomon DS; Hendrix MJ
Cell Cycle; 2013 May; 12(9):1450-6. PubMed ID: 23574716
[TBL] [Abstract][Full Text] [Related]
2. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
3. Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer.
Francescangeli F; Contavalli P; De Angelis ML; Baiocchi M; Gambara G; Pagliuca A; Fiorenzano A; Prezioso C; Boe A; Todaro M; Stassi G; Castro NP; Watanabe K; Salomon DS; De Maria R; Minchiotti G; Zeuner A
Cell Death Differ; 2015 Oct; 22(10):1700-13. PubMed ID: 26343543
[TBL] [Abstract][Full Text] [Related]
4. Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma.
Strizzi L; Abbott DE; Salomon DS; Hendrix MJ
Cell Cycle; 2008 Jul; 7(13):1931-5. PubMed ID: 18604175
[TBL] [Abstract][Full Text] [Related]
5. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32649753
[TBL] [Abstract][Full Text] [Related]
6. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32648918
[TBL] [Abstract][Full Text] [Related]
7. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional role of CRIPTO-1 in cutaneous melanoma.
De Luca A; Lamura L; Strizzi L; Roma C; D'Antonio A; Margaryan N; Pirozzi G; Hsu MY; Botti G; Mari E; Hendrix MJ; Salomon DS; Normanno N
Br J Cancer; 2011 Sep; 105(7):1030-8. PubMed ID: 21863025
[TBL] [Abstract][Full Text] [Related]
9. Liver-specific over-expression of Cripto-1 in transgenic mice promotes hepatocyte proliferation and deregulated expression of hepatocarcinogenesis-related genes and signaling pathways.
Liu Y; Li YQ; Huang SH; Li YL; Xia JW; Jia JS; Wei F; Wang JH; Dai GQ; Wang YC; Li XY; Han LX; Zhang XL; Xiang XD; Zhao WT; Xiao D; Lin XL
Aging (Albany NY); 2021 Sep; 13(17):21155-21190. PubMed ID: 34517344
[TBL] [Abstract][Full Text] [Related]
10. Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.
Alam MJ; Takahashi R; Afify SM; Oo AKK; Kumon K; Nawara HM; Khayrani AC; Du J; Zahra MH; Seno A; Salomon DS; Seno M
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373174
[TBL] [Abstract][Full Text] [Related]
11. Administration of Cripto in GRP78 overexpressed human MSCs enhances stem cell viability and angiogenesis during human MSC transplantation therapy.
Kim S; Yoon YM; Han YS; Lee JH; Hur J; Lee SH
Cell Prolif; 2018 Oct; 51(5):e12463. PubMed ID: 29722092
[TBL] [Abstract][Full Text] [Related]
12. Role of Cripto-1 in stem cell maintenance and malignant progression.
Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
[TBL] [Abstract][Full Text] [Related]
13. Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells.
Arnouk H; Yum G; Shah D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502188
[TBL] [Abstract][Full Text] [Related]
14. CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.
Zoni E; Chen L; Karkampouna S; Granchi Z; Verhoef EI; La Manna F; Kelber J; Pelger RCM; Henry MD; Snaar-Jagalska E; van Leenders GJLH; Beimers L; Kloen P; Gray PC; van der Pluijm G; Kruithof-de Julio M
Oncogene; 2017 Aug; 36(33):4739-4749. PubMed ID: 28394345
[TBL] [Abstract][Full Text] [Related]
15. Autoregulation and heterogeneity in expression of human Cripto-1.
Loying P; Manhas J; Sen S; Bose B
PLoS One; 2015; 10(2):e0116748. PubMed ID: 25658584
[TBL] [Abstract][Full Text] [Related]
16. Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome.
Xue YJ; Chen SN; Chen WG; Wu GQ; Liao YF; Xu JB; Tang H; Yang SH; He SY; Luo YF; Wu ZH; Huang HW
J Exp Clin Cancer Res; 2019 Aug; 38(1):378. PubMed ID: 31455359
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Cripto-1 inhibits the proliferation, migration, invasion, and angiogenesis in prostate carcinoma cells.
Wu D; Shi Z; Xu H; Chen R; Xue S; Sun X
J Biosci; 2017 Sep; 42(3):405-416. PubMed ID: 29358554
[TBL] [Abstract][Full Text] [Related]
18. Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis.
Gray PC; Vale W
FEBS Lett; 2012 Jul; 586(14):1836-45. PubMed ID: 22306319
[TBL] [Abstract][Full Text] [Related]
19. CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.
Terry S; El-Sayed IY; Destouches D; Maillé P; Nicolaiew N; Ploussard G; Semprez F; Pimpie C; Beltran H; Londono-Vallejo A; Allory Y; de la Taille A; Salomon DS; Vacherot F
Oncotarget; 2015 May; 6(14):11994-2008. PubMed ID: 25596738
[TBL] [Abstract][Full Text] [Related]
20. The expression of the embryonic gene Cripto-1 is regulated by OCT4 in human embryonal carcinoma NCCIT cells.
Park SW; Do HJ; Han MH; Choi W; Kim JH
FEBS Lett; 2018 Jan; 592(1):24-35. PubMed ID: 29223130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
